Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Cobalin-H 1000 microgram/ml Injection

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Hydroxocobalamin may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Hydroxocobalamin
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

FOR This medicine contains hydroxocobalamin which is a form of Vitamin B 12. Vitamin B12 contains cobalt. Hydroxocobalamin is given for:

  • Addisonian pernicious anaemia (caused when absorption of Vitamin B 12 from the stomach is reduced).
  • Tobacco amblyopia (poor sight caused by toxins such as tobacco).
  • Leber's atrophy (degeneration of the optic nerve resulting in loss of central vision).
  • Treatment/prevention of other macrocytic anaemias due to deficiency in vitamin B12. Vitamin B12 is needed for physical growth and development and for the formation of red blood cells in the bone marrow. It is also required for absorption of folic acid and carbohydrates from food and for keeping the nerve (neurological) system healthy. The body only requires a small amount of the vitamin daily so a deficiency may take months or even years to develop. Eventually, the formation of abnormally large red blood cells (macrocytes)with reduced ability to carry oxygen from enlarged cells (megaloblasts) in the bone marrow, gives rise to anaemia. Symptoms of Vitamin B 12 deficiency anaemia include sore mouth and tongue, numbness and tingling in the arms and legs, memory loss and depression. This injection is usually given to you by your doctor or someone else trained to give it to you. 2. WHAT YOU NEED TO KNOW BEFORE COBALIN-H INJECTION IS GIVEN Do not use Cobalin-H Injection:
  • If you are allergic to active substance or any of the other ingredients of this medicine (listed in section 6). Warnings and Precautions: Talk to your doctor, pharmacist or nurse before you are given Cobalin-H Injection
  • If you are aware of abnormal heart beats, tell your doctor or nurse.
  • If, after several weeks' treatment, you do not feel any improvement, discuss this with your doctor or nurse.
  • If you have a known cobalt allergy. Other medicines and Cobalin-H Injection Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Cobalin-H Injection can interfere with the action of some other drugs and some drugs can have an effect on Cobalin-H Injection. The following drugs can cause some problems when taken together with Cobalin-H Injection:
  • chloramphenicol (an antibiotic) can reduce the effects of Cobalin-H Injection.
  • oral contraceptives may reduce the blood levels of Cobalin-H Injection. The following medicines do not alter the effectiveness of Cobalin-H Injection but make it more difficult to measure the amount of Vitamin B12 in the body:
  • antibiotics.
  • antimetabolites (used to treat tumours and blood disorders). Pregnancy, breast feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Pregnancy Cobalin-H Injection should not be used for the treatment of megaloblastic anaemia of pregnancy. Breast feeding If you are breast feeding you should tell your doctor before you are given this medicine. Cobalin-H Injection passes into the breast milk but is unlikely affect your baby. Fertility No data available Driving and using machines Your medicine is unlikely to affect your ability to drive or to operate machinery. However, some people may feel dizzy or drowsy when given Cobalin-H Injection. If this happens to you, do not drive or operate machinery.

Cobalin-H Injection contains sodium Cobalin-H Injection contains less than 1mmol sodium (23 mg) per 1ml that is to say essentially 'sodium-free'.

How to take it

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Cobalin-H Injection will be given to you by injection into a muscle. The dose depends on your individual needs and responses to treatment. Your blood levels of Vitamin B 12 and folic acid are likely to be monitored both before and during treatment. If you have doubts about the treatment or want more information about your medicine or the monitoring procedure, do ask the doctor or nurse. The recommended dose is Adults and Children Initial dose: This varies between 250 microgram and 1000 microgram given daily or on alternative days. The actual dosage depends on your specific illness and your response to treatment. Maintenance dose: Your doctor will check your condition regularly. When he/she feels that your health has improved sufficiently, your dose of Cobalin-H Injection will be reduced to 1mg every 2-3 months or as required. If you use more Cobalin-H Injection than you should: Being given more than the intended dose of hydroxocobalamin is unlikely to cause a problem requiring treatment. Tell the doctor if you are experiencing any side effects or think you may be reacting badly so that he/she can give appropriate treatment. If you have already left the medical premises, contact your nearest hospital, doctor or nurse. If you forget to take Cobalin-H injection: It is unlikely that you will miss a dose as your doctor or nurse will be giving it to you. However, it is important not to have a double dose if you have missed one. Ask your doctor or nurse when you should have the next dose. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 4. POSSIBLE SIDE EFFECTS Like all medicines this medicine can cause side effects, although not everybody gets them. Tell your doctor immediately if you experience any of the following symptoms after you have been given the injection. Although they are very rare, these symptoms can be serious.

  • swelling of the lips and face, difficulty in breathing, skin rash and redness (these may be symptoms of a serious allergic reaction)
  • irregular heartbeat (caused by low levels of potassium in the blood) during early stages of treatment. Rare: may affect up to 1 in 1,000 people  Acniform and bullous eruptions (acne-like and blistery skin eruptions) Not known: frequency cannot be estimated from the available data  Headache, dizziness  Nausea (feeling sick), vomiting, diarrhoea  Malaise (feeling unwell)  Rash, itching  Injection site reactions including injection site pain, injection site erythema, injection site pruritus, injection site induration, and injection site swelling (Reactions at the site of the injection)  Exanthema (a widespread skin rash)  Chromaturia (unusual coloured urine)  Fever  Hot flushes (a feeling of intense heat with sweating and rapid heartbeat)  Chills (feeling of coldness accompanied by shivering)  Paraesthesia (feeling of pins and needles)  Tremor (tremble or shakes)  Hypokalaemia (decreased potassium levels in the blood)  Reactive thrombocytosis (body produces too many platelets) Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

How to store it

COBALIN-H INJECTION Keep this medicine out of the sight and reach of children. Store below 25oC and protect from light. The product should not be used if it is not a clear red liquid or if it contains visible particles. Do not use this medicine after the expiry date which is stated on the ampoule and carton after "EXP". The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Cobalin-H Injection contains The active substance is: hydroxocobalamin 1000 microgram/ml.

The other ingredients are: sodium dihydrogen orthophosphate, sodium chloride and Water for Injections with sodium hydroxide and/or hydrochloric acid as pH adjusters. The product is suitable for vegetarians and vegans. What Cobalin-H Injection looks like and contents of the pack The product is a clear red liquid, supplied in 5 clear glass vials. Each vial contains 1000 micrograms hydroxocobalamin. Marketing Authorisation Holder Amdipharm UK Limited, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom (send all enquiries to this address). Manufacturer Mercury Pharmaceuticals Limited, Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom ®Cobalin-H injection is a registered trade mark PL 20072/0217 This leaflet was last revised in April 2024.

Frequently asked questions about Cobalin-H 1000 microgram/ml Injection

How do I take Cobalin-H 1000 microgram/ml Injection?

Cobalin-H 1000 microgram/ml Injection comes as injection containing 1000microgram/ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Cobalin-H 1000 microgram/ml Injection?

The active substance in Cobalin-H 1000 microgram/ml Injection is hydroxocobalamin.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Cobalin-H 1000 microgram/ml Injection, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Cobalin-H 1000 microgram/ml Injection without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Hydroxocobalamin (3 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Treatment of Addisonian pernicious anaemia.

Prophylaxis and treatment of other macrocytic anaemias due to vitamin B12 deficiency.

Treatment of tobacco amblyopia.

Treatment of Lieber's atrophy.

4.2. Posology and method of administration

Posology

The following dosages are suitable for children and adults.

Addisonian pernicious anaemia and other macrocytic anaemias without neurological involvement:

Initially:

250 micrograms to 1000 micrograms intramuscularly on alternate days for one or two weeks then 250 micrograms weekly until blood count is normal.

Maintenance:

1000 micrograms every two or three months.

Addisonian pernicious anaemia and other macrocytic anaemias with neurological involvement:

Initially:

1000 micrograms on alternate days as long as improvement continues.

Maintenance:

1000 micrograms every two months.

Prophylaxis of macrocytic anaemias associated with vitamin B12 deficiency resulting from gastrectomy, ileal resection, certain ma/absorption states and vegetarianism:

1000 micrograms every two or three months.

Tobacco amblyopia and Leber's optic atrophy:

Initially:

1000 micrograms daily by intramuscular injection for two weeks then twice weekly as long as improvement is maintained.

Maintenance:

1000 micrograms every three months or as required.

Method of Administration

Intramuscular injection

4.3. Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

4.4. Special warnings and precautions for use

It is advisable to confirm the diagnosis of Vitamin B12 deficiency before giving hydroxocobalamin; regular monitoring of the blood is recommended.

If megaloblastic anaemia fails to respond, folate metabolism should be investigated.

Doses in excess of 10 micrograms daily may produce a haematological response in patients with folate deficiency. Indiscriminate administration may mask the true diagnosis.

Cardiac arrhythmias secondary to hypokalaemia during initial therapy have been reported. Plasma potassium should therefore be monitored during this period.

4.5. Interaction with other medicinal products and other forms of interaction

Chloramphenicol

Parenteral chloramphenicol may attenuate the effect of hydroxocobalamin in anaemia.

Oral contraceptives

The serum concentration of hydroxocobalamin may be lowered.

The above interactions are unlikely to be of clinical significance but should be taken into account when performing assays for blood concentrations.

Vitamin B12 assays by microbiological techniques are invalidated by antimetabolites and most antibiotics.

4.6. Fertility, pregnancy and lactation

Pregnancy

Hydroxocobalamin injection should not be used for the treatment of megaloblastic anaemia of pregnancy.

Breast-feeding

Hydroxocobalamin is secreted into breast milk but is unlikely to harm the infant.

Fertility

No data available

4.7. Effects on ability to drive and use machines

Not relevant.

4.8. Undesirable effects

The following adverse reactions are classified by system organ class and ranked under heading of frequency using the following convention:

Not known (cannot be estimated from the available data)

There are no modern clinical studies available that can be used to determine the frequency of undesirable effects. Therefore, all the undesirable effects listed are classed as “frequency Not known”.

The following effects have been reported and are listed below by body system:

System organ class

Frequency

Undesirable effects

Blood and lymphatic system disorders

Not Known

Reactive thrombocytosis can occur during the first weeks of use in megaloblastic anaemia.

Immune system disorders

Not Known

Hypersensitivity reactions including rash; itching; exanthema. Antibodies to hydroxocobalamin-transcobalamin II complex have developed during hydroxocobalamin therapy.

Anaphylaxis

Metabolism and nutrition disorders

Not Known

Initial hypokalaemia

Nervous system disorders

Not Known

Headache, paraesthesia, tremor.

Cardiac disorders

Not Known

Arrhythmias secondary to hypokalaemia.

Gastrointestinal disorders

Not Known

Nausea, vomiting, diarrhoea.

General disorders and administration site conditions

Not Known

Fever, chills, hot flushes; dizziness; malaise; pain; Injection site reactions including injection site pain, injection site erythema, injection site pruritus, injection site` induration, and injection site swelling.

Skin and subcutaneous tissue disorders

Not known

Acneiform and bullous eruptions

Renal and urinary disorders

Not Known

Chromaturia

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme Website : www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Treatment is unlikely to be needed in case of overdose.

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

  • CyanokitHydroxocobalaminum · injection / infusion

Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Cobalin-H 1000 microgram/ml Injection. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →